Individuals taking medications for diabetes, thyroid disorders, or other metabolic conditions should use AOD-9604 only under medical supervision with appropriate monitoring
Your provider can explain trade-offs based on your goals and medical history
What lipotropic injections plausibly contribute is more modest and more defensible: correction of real deficiencies, a tolerable non-stimulant option for patients who cannot or will not take prescription weight loss medication, and a recurring touchpoint that keeps patients engaged with a supervised program
Food & Drug Administration (2025) Ozempic, DailyMed (2025) Wegovy, DailyMed (2024) Once-weekly semaglutide in adults with overweight or obesity, New England Journal of Medicine (2021) Vitamin B12, National Institutes of Health Office of Dietary Supplements (2024) Vitamin B12 injections: What they can and cant do, Cleveland Clinic (2024) Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes, Obesity Pillars (2024) Inverse association between serum vitamin B12 concentration and obesity among adults in the United States, Frontiers in Endocrinology (Lausanne) (2019) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
5-Amino-1MQ is studied for its possible effect on NNMT, metabolism, fat cell activity, NAD-related pathways, and cellular aging
